Status:
COMPLETED
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
RATIONALE: Eating a diet high in soy foods may slow the progression of some types of cancer. Isoflavones are compounds found in soy food that may slow the growth of prostate cancer cells and prevent f...
Detailed Description
OBJECTIVES: * Determine the effect of soy protein isolate (isoflavones) and radiotherapy on the modulation of biomarkers in patients with localized prostate cancer. * Determine the toxicity of this r...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed adenocarcinoma of the prostate that is localized to the prostate gland
- Must be scheduled to receive curative radiotherapy for prostate cancer
- Not eligible for a higher priority study at the Karmanos Cancer Institute
- PATIENT CHARACTERISTICS:
- Performance status
- 0-3
- Life expectancy
- Not specified
- Hematopoietic
- Not specified
- Hepatic
- Not specified
- Renal
- Not specified
- Other
- No organ function restrictions
- PRIOR CONCURRENT THERAPY:
- Chemotherapy
- No prior chemotherapy
- Endocrine therapy
- No prior hormonal therapy
- Radiotherapy
- See Disease Characteristics
- Other
- No other concurrent micronutrient supplements, herbs, or vitamins except 1 daily multivitamin
Exclusion
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00243048
Start Date
May 1 2002
End Date
October 1 2007
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States, 48201-1379